BS
The startup develops a liquid biopsy kit that collects blood and urine samples to detect renal cell carcinoma biomarkers. This technology enables healthcare providers to identify kidney masses in patients, facilitating earlier diagnosis and improved patient outcomes.
Updated 3 months ago
Funding
$330K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a liquid biopsy kit that collects blood and urine samples to detect renal cell carcinoma biomarkers. This technology enables healthcare providers to identify kidney masses in patients, facilitating earlier diagnosis and improved patient outcomes.